Biobis-Pharma
Medical Cannabis
Health Tech & Life Sciences
Non Active, Mar 2023 ceased to operate
Company Overview
Snapshot
Founded in February 2018 by Ram Sarfaty and Ziv Eisner, Biobis-Pharma operated with 1–10 employees. The company ceased operations in March 2023.
Business overview
Biobis-Pharma specializes in providing cannabis solutions for pharmaceutical companies, drug developers, and retailers. The company focuses on delivering top-quality, pharmaceutical-grade products by adhering to stringent standard operating procedures and methodologies common in the pharmaceutical and medical device industries. Leveraging a worldwide network of manufacturing facilities, Biobis-Pharma aimed to ensure high product availability and competitive cost structures within the Health Tech & Life Sciences sector, specifically targeting the Medical Cannabis market.
Log in to access full profile ›Company Intelligence Q&A
- What is Biobis-Pharma's primary focus?
- Biobis-Pharma focuses on providing cannabis solutions for pharmaceutical companies, drug developers, and retailers, emphasizing pharmaceutical-grade products and stringent operational procedures.
- When was Biobis-Pharma founded?
- Biobis-Pharma was founded in February 2018.
- Who are the co-founders of Biobis-Pharma?
- Ram Sarfaty and Ziv Eisner are the co-founders of Biobis-Pharma.
- What is the operational status of Biobis-Pharma?
- Biobis-Pharma ceased to operate in March 2023.
- Which markets does Biobis-Pharma serve?
- Biobis-Pharma serves the United States market.